No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
Low dose-rate brachytherapy for the treatment of cervix cancer is outdated and should be discontinued
R. Paterson, H. M. Parker, F. W. Spiers, M. C. Tod, S. K. Stephenson, and W. J. Meredith, Radium Dosage: The Manchester System, 2nd ed. (E. & S. Livingston, Edinburgh, London, 1967), pp. 47–48.
M. Dolezel, K. Odrazka, J. Vanasek, T. Kohlova, T. Kroulik, K. Kudelka, D. Spitzer, M. Mrklovsky, M. Tichy, J. Zizka, and L. Jalcova, “MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy,” Br. J. Radiol. 84, 850–856 (2011).
D. G. Petereit, J. N. Sarkaria, D. M. Potter, and J. C. Schink, “High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence—The University of Wisconsin experience,” Int. J. Radiat. Oncol., Biol., Phys. 45, 1267–1274 (1999).
A. J. Stewart and A. N. Viswanathan, “Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer,” Cancer 107, 908–915 (2006).
A. N. Viswanathan, S. Beriwal, S. J. De Los, J. Demanes, D. Gaffney, J. Hansen, E. Jones, C. Kirisits, B. Thomadsen, and B. Erickson, “The American Brachytherapy Society treatment recommendations for locally advanced carcinoma of the cervix. Part II: High dose-rate brachytherapy,” Brachytherapy 11(1), 47–52 (2012).
P. M. Devlin, R. A. Cormack, C. L. Holloway, and A. J. Stewart, Brachytherapy Applications and Techniques, 2nd ed. (Demos Medical, New York, NY, 2016), pp. 139–164.
H. Kucera, R. Pötter, T. H. Knocke, M. Baldass, and E. Kucera, “High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer,” Wien. Klin. Wochenschr. 113, 58–62 (2001).
International Atomic Energy Agency, “Lessons learned from accidental exposure in radiotherapy,” IAEA Safety Reports Series No. 17 (IAEA, Vienna, 2000).
J. F. Williamson, P. W. Grigsby, A. S. Meigooni, and S. Teague, “Clinical physics of pulsed dose rate remotely-afterloaded Brachytherapy,” in Brachytherapy Physics, edited byJ. F. Williamson, B. R. Thomadsen, and R. Nath (Medical Physics, Madison, WI, 1995), pp. 577–616.
L. J. Lee, I. J. Das, S. A. Higgins, A. Jhingran, W. Small, B. Thomadsen, A. N. Viswanathan, A. Wolfson, and P. Eifel, “American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: Low-dose-rate and pulsed-dose-rate brachytherapy,” Brachytherapy 11, 53–57 (2012).
F. Mourtada, K. A. Gifford, P. A. Berner, J. L. Horton, M. J. Price, A. A. Lawyer, and P. J. Eifel, “Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids,” Med. Dosim. 32, 181–187 (2007).
J. G. Couto, I. Bravo, and R. Pirraco, “Biological equivalence between LDR and PDR in cervical cancer: Multifactor analysis using the linear-quadratic model,” J. Contemp. Brachytherapy 3, 134–141 (2011).
R. Liu, L. R. Wang, J. H. Tian, K. Yang, J. Wang, L. Jiang, and X. Y. Hao, “High dose rate versus low dose rate intracavitary brachytherapy for locally advanced uterine cervix cancer,” Cochrane Database Syst. Rev. 7, CD007563 (2014).
Article metrics loading...
There is no abstract available for this article.
Full text loading...
Most read this month